HEYL Chemisch-pharmazeutische Fabrik GmbH & Co. KG is an independent family business based in Berlin, which has existed since 1926. The company has focused on the development and marketing of specialty drugs, especially Antidotes against heavy metal and radionuclide poisoning as well as treatments for Morbus Wilson, rheumatoid arthritis, Toxoplasmosis and specific Vitamin deficiencies[1][2][6].
The main products include Antidotes against toxins such as Thallium, Arsenic, heavy metals such as Mercury and Lead, as well as radioactive isotopes such as Cesium and Plutonium. These drugs are developed in cooperation with national and international research institutions[1][5]. The company also distributes [1][5].
HEYL's mission is to develop highly effective and safe drugs in specialized areas. The company is committed to close cooperation with research institutions and universities to continuously develop new and effective treatments[1][6].
Information on specific sustainability goals or initiatives is not included in the information provided. However, the company focuses on the further development of its products and close cooperation with research institutions, which contribute to the development of safe and effective drugs[1][6].
HEYL is not only active in Germany, but also internationally through subsidiaries such as Heyltex in Houston, Texas, and Heyl Japan in Tokyo[1][5].
